LATS1 and ovarian cancer: Compared to cisplatin-resistant ovarian cancer cells (A2780-CP), the expression of LATS1/2 and p-YAP was increased in cisplatin-sensitive ovarian cancer cells (A2780-S), and the expression of senescence-related proteins was increased (Fig. 4D).